Franklin Biotechnology Discv C Acc $

Performance History30/04/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv C Acc $
Fund101.547.939.8-28.010.2
+/-Cat6.53.9-3.81.0-1.0
+/-Idx-5.63.5-4.4-5.52.7
 
Key Stats
NAV
26/05/2017
 USD 34.30
Day Change -0.36%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0260873095
Fund Size (Mil)
30/04/2017
 USD 2516.29
Share Class Size (Mil)
30/04/2017
 USD 16.87
Max Initial Charge -
Ongoing Charge
27/01/2017
  2.41%
Investment Objective: Franklin Biotechnology Discv C Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/05/2017
YTD0.95
3 Years Annualised14.98
5 Years Annualised27.34
10 Years Annualised18.11
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
01/09/2006
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv C Acc $30/04/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks92.850.0092.85
Bonds0.000.000.00
Cash6.040.006.04
Other1.110.001.11
Top 5 Regions%
United States96.70
United Kingdom0.94
Middle East0.89
Canada0.69
Eurozone0.62
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.26
Biogen IncHealthcareHealthcare6.26
Alexion Pharmaceuticals IncHealthcareHealthcare5.86
Incyte CorpHealthcareHealthcare5.63
Tesaro IncHealthcareHealthcare5.47
Franklin Biotechnology Discv C Acc $